Answers are grounded in this paper and cite their sources.
BACKGROUND: . In humans, CHIP associates with prevalent myocardial infarction. In mice, CHIP accelerates atherosclerosis and increases IL-6/IL-1β expression, raising the hypothesis that IL-6 pathway antagonism in CHIP carriers would decrease cardiovascular disease (CVD) risk. METHODS: p.Asp358Ala. CONCLUSIONS: CHIP is associated with increased risk of incident CVD. Among carriers of large CHIP clones, genetically reduced IL-6 signaling abrogated this risk.
No takes yet. Share an insight, caveat, or question.
Bick et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: